Chemical genetics is a research approach that uses small molecules as probes to study protein functions in cells or whole organisms. Here, I review the parallels between classical genetic and chemicalgenetic approaches and discuss the merits of small molecules to dissect dynamic cellular processes. I then consider the pros and cons of different screening approaches and specify strategies aimed at identifying and validating cellular target proteins. Finally, I highlight the impact of chemical genetics on our current understanding of cell biology and its potential for the future.
It is an omnipresent challenge for every cell biologist to dissect a complex biological process within a cellular system. In general, it is not only the number of the participating components but also the complexity of their regulation and interactions that constitute this daunting task. Historically, genetic approaches have proven to be extremely powerful in elucidating the principles of a wide range of biological processes such as cell division in the budding yeast Saccharomyces cerevisiae [1] , programmed cell death and organ development in the nematode Caenorhabditis elegans [2] or early embryonal development in the fruitfly Drosophila melanogaster [3] . These famous screens, honored by the Nobel Prize, are classical examples of forward-genetic approaches, which can be outlined by a three-step procedure: first, the genome of the chosen organism has to be mutagenized in a random fashion (e.g. EMS, X-ray, transposons), then the desired phenotype has to be detected within the large collection of generated mutants and, finally, the mutated gene that underlies the phenotype has to be identified. Whereas the forward-genetic method works its way from the desired phenotype 'forward' to the underlying mutated gene, reverse-genetics elucidates the function of a protein of interest by analyzing the phenotype when the encoding gene is mutated. In these studies, the introduced mutations can either affect the activity of the chosen protein (e.g. site-specific mutations) or entirely suppress its expression (e.g. 'knockout' mutations).
What is chemical genetics and why make use of it?
The term 'chemical genetics' has been coined for an approach that uses small organic molecules (see Fig. 1 
)
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as probes to study protein functions in cultured cells or whole organisms. In accordance with the aforementioned genetic approaches, we can distinguish between forwardand reverse-chemical genetics. A forward-chemical genetic screen -like its genetic counterpart -can be subdivided into three discrete steps: first, the organism or cell type of interest has to be treated with a diverse collection of small molecules. This step mirrors the introduction of random genetic mutations in the forwardgenetic approach. The goal of the second step is to identify the desired phenotype within the large collection of compound-treated organisms or cells and, finally, the cellular molecules (e.g. proteins, lipids, sugars) targeted by the bioactive compounds have to be identified. Similar to the genetic approach, the starting point for reverse chemical genetics is a protein of interest for which bioactive ligands are searched out of a large pool of small molecules.
An interesting combination of reverse genetics with chemistry is provided by a recent approach pioneered by Shokat and colleagues [4] . The underlying idea of their method is to genetically engineer a mutant nucleotide binding protein (e.g. kinase, motor protein), which becomes sensitive to a nucleotide analog but retains almost normal enzymatic activity in the presence of the wild-type nucleotide. In this way, the mutant allele can be inhibited by the nucleotide analog in a cellular context, whereas all other wild-type nucleotide binding proteins remain essentially unaffected (see below).
The genetic approach is powerful in that it can readily identify gene products involved in a specific process and then mutate the encoding gene with complete specificity within a complex cellular context. However, there are situations in which small molecules might be more useful. First, in many cases, one and the same small molecule can be applied to study a process of interest in a wide range of organisms, whereas the genetic approach logically demands that the desired genetic modification has to be regenerated every time the experimental system is switched. For example, brefeldin A was instrumental to study transport processes from the endoplasmic reticulum (ER) to Golgi in organisms as different as yeasts, plants and mammalian cells [5] .
Second, most mutations are not conditional, which means that the activity of the protein of interest cannot be turned on or off at will. And even if conditional alleles are available (e.g. temperature-sensitive mutations or mutant alleles under the control of inducible promoters), it typically (g) Fig. 1 . Chemical structures of small molecules discussed in this review: (a) taxol, (b) BTS, (c) ilimaquinone, (d) BH31-1, (e) IIA4B20, (f) colchicine, (g) splitomicin, (h) synstab A, (i) monastrol, (j) latrunculin A. In the context of this review, the term 'small molecules' is applied to all organic compounds with a molecular mass of less than 1500 Da, which have been either chemically synthesized or isolated from biological extracts. (For a review on peptide and peptidomimetic inhibitors, see [66] ).
requires hours to change the protein complement of a cell. This lack of temporal control substantially limits the use of genetic approaches to study dynamic processes. By contrast, small molecules change directly the way proteins work, thereby representing tools with a uniquely high temporal resolution, capable of dissecting dynamic cellular processes. Notably, small molecules bear the potential to gain insights into fundamental biological processes not only by studying compound-treated cells but also by observing cells released from compound treatments. For example, the role of the microtubule-organizing center (MTOC) in nucleating microtubules was initially recognized by studies of cultured cells recovering from treatment with the microtubule poison colcemid [6] .
Of particular interest, chemical genetics is predestined to pave the way for interdisciplinary research uniting biology, chemistry, pharmacology and medicine. In this way, basic research has the potential to create promising leads for the development of new therapeutic drugs. Of particular note, small molecules targeting microtubules represent impressive examples of synergies between basic research and drug development: colchicine was first used over 2000 years ago in the form of preparations of the meadow saffron Colchicum autumnale to treat pain associated with gout attacks. After the isolation of (-)-colchicine as the active constituent of the plant by the French chemists Pelletier and Caventon in 1820, this compound led to the discovery of tubulin by Taylor and colleagues in the late 1960s [7] . Today, colchicine is still one of the more effective treatments for gout, and, at the same time, it is a versatile probe to study microtubule functions in diverse cell-biological processes such as cell migration, trafficking .
of intracellular vesicles or mitosis [8] . Taxol, the active compound from the bark of the Pacific yew tree (Taxus brevifolia), was identified in 1971 as a substance with antitumor activity and is today an approved drug to treat breast and ovarian cancer [9] . Unlike most other microtubule poisons (e.g. colchicine, nocodazole, the Vinca alkaloids), taxol actually promotes the polymerization of microtubules in vitro and in vivo [10, 11] and therefore plays an essential role in almost all experiments requiring artificial microtubule polymerization (e.g. purification of microtubule-associated proteins or studies on microtubulebased motor proteins in vitro [12, 13] ).
The foundation of chemical screens: small-molecule libraries
In the past, biologically active small molecules have been mainly identified in complex biological mixtures derived from plants, marine sponges, fungi or bacteria. Obviously, this approach bears the risk that the initially observed activity is caused by the synergistic effect of numerous compounds rather than by a single small molecule. One way to circumvent this pitfall is to use large collections of defined, structurally diverse small molecules. However, until recently, this approach was restricted to pharmaceutical companies, who have assembled chemical libraries in the order of hundreds of thousands of compounds over the past century.
The enormous progress achieved in the field of combinatorial chemistry (see Box 1) [14] , which has allowed the rapid production of a large number of chemically diverse molecules, was an important prerequisite to make chemical libraries available to academic researchers. As a result, a Box 
Definition ofterms
Combinatorial chemistry: A strategy to synthesize multiple compounds in one step by combining variations of the different building blocks in the same reaction mixture. In this way, a single reaction carried out with, for example, five derivatives of reactant A and five derivatives of reactant B can yield .25 structurally related products.
Whole-cell immunoassay: Chemiluminescent-based method to detect an antigen of interest in whole cells fixed in microtitre plates using a specific primary antibody and a secondary antibody coupled to horseradish peroxidase.
Phage display: A method to individually display peptides and proteins on the surface of a small bacterial virus called a phage.
Interactions between the displayed peptides or proteins and the small molecule of interest can be detected by using a traceable derivative of the compound (radioactive or otherwise taggede.g. biotin).
Protein microarray: High-throughput device to detect proteinprotein, protein-substrate orprotein-small-molecule interactions. Protein microarrays are created by the covalent attachment of peptides or proteins on g lass supports. The identification of smallmolecule interaction partners follows the same strategy depicted for phage display.
Three-hybrid system: this is based on a synthetic hybrid molecule composed of a compound with a known binding partner (e.g. dexamethasone, which binds to the hormone-binding domain of the glucocorticoid receptor) and the small molecule of interest (Fig. I ).
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No transcription mL", (, Given the challenge that typically tens of thousands of compounds have to be analyzed to find the desired bioactive molecules, it is self-evident that the intended screen has to be robust, automated as far as possible and miniaturized to an extent compatible with the 96-, 384-or even 1536-well format. In the process of designing a suitable screening approach, the first and major decision to be made is between a 'pure protein' and a 'cell-based' assay (see Fig. 2 ). Pure-protein screens are performed in vitro through binding or enzymatic assays using mainly optical readouts such as luminescence, absorbance or fluorescence (e.g. fluorescence intensity, fluorescence polarization, fluorescence resonance energy transfer [18] ). By contrast, cell-based assays ensure that the target protein exists in its physiological context and that the identified molecules are membrane-permeable. A common cell-based approach is the reporter-gene assay, where the accumulation of an easily detectable enzymatic activity (e.g.luciferase) depends on the activity of the target protein (e.g. a transcriptional regulator). Alternatively, cell-based approaches can make use offunctional readouts (e.g. cell viability) or of 'wholecell immunoassays' (see Box 1), a luminescence-based method that uses a suitable antibody to detect an epitope in cells whose occurrence or disappearance can be used as a readout for a specific process of interest [19J. These latter two cell-based methods are not biased towards one particular protein but are conceptually broader, offering the potential to find compounds for poorly characterized or even unknown targets. Microscope-based approaches represent a new and exciting trend in cell-based screening towards acquiring more complex data. Unlike the aforementioned methods, this approach is capable of detecting subtle morphological changes (see Fig. 3 ). Moreover, microscope-based methods have the great advantage that they allow the collection not only of data on the specific process under investigation but also data on effects indirectly influencing the process of interest. For example, in a screen for inhibitors of cell migration (see Fig. 3 ), the total cell count can be applied to identify and sort out cytotoxic compounds, whose inhibitory activity on cell migration is indirectly caused by the fact that the cells are dying. Recently, this type of approach, which obviously demands the use of automated microscopes and image-analysis software [20] , has been successfully applied to identify small molecules interfering with a wide range of biological processes, including embryonic development [21] , cell differentiation [22) and the transport of intracellular vesicles [23) . Table 1 highlights examples ofbioactive compounds that have been recently identified via pure-protein or cell-based screens.
Target identification and validation
Target identification represents a major challenge for all forward-chemical genetic screens (see above). In the past, biochemical purifications have been the method of choice for target identification. The two main routes are either to follow a traceable (radioactive or otherwise tagged -for example -biotin) derivative of the bioactive compound during fractionation of cell extracts or to immobilize the compound via a chemicallinker on a solid phase support, followed by affinity purification of the cellular target [24) . Biochemical methods have been exceptionally successful in target identification (see Table 2 ). However, this approach reaches its limits when chemical modifications of the compound are not compatible with its biological activity or when the small molecule lacks a sufficiently high binding affinity for the isolation of target proteins that are only present in low abundance. By applying cDNA expression-based methods such as phage display [25) , protein microarrays [26) or yeast 'three-hybrid systems' [27) , the abundance of the target protein can be artificially increased. Phage display methods and protein microarrays follow the same basic concept (see Box l):a tagged compound (see above) is used as a probe to identify its binding partner within a collection of spatially separated proteins. The basis of the yeast three-hybrid system is a synthetic hybrid molecule composed of a compound with a known binding partner (e.g. dexamethasone, which binds to the hormone-binding domain of the glucocorticoid receptor) and the small molecule of interest (see Fig. I in Box 1). Under conditions where one part of Ref. [32] [60J [61J [62] [63] [64J [65J the hybrid molecule (dexamethasone) binds to its known ligand fused to the DNA-binding domain and the other part (small molecule of interest) binds at the same time to its target fused to the activation domain, transcription will be activated, enabling the expression of a reporter gene (e.g. an essential metabolic enzyme).
New genetic-based approaches for target identification became applicable by the advent of whole-genome sequence information. One possible approach, termed the haploinsufficiency method, follows the logic that lowering the gene dosage from two copies down to one copy sensitizes yeast cells to the drug that acts on the gene product. Recently, this approach was validated on known targets of six small molecules [28) . An alternative approach, which is applicable to yeast as well as to higher eukaryotes, is based on the rationale that increasing the gene dosage of the target gene renders cells more resistant to the compound [29) . A key advantage of these genetic approaches is that they do not require chemical modifications of the selected compound.
At the end of any chemical screen, selected compounds have to pass the acid test of specificity and selectivity. In a first attempt, specificity can be assessed by testing whether the compound modifies the activity of target-related proteins in vitro. But no matter how many proteins are tested in vitro, the risk remains that the assumed target is not the relevant binding partner in vivo. Therefore, additional experiments are required to validate the target. In the case of small molecules with an inhibitory mode of action, one possible strategy is to test whether the compound-induced phenotype can be either mimicked by shutting down the activity of the suspected target protein (by biochemical or genetic methods such as immunodepletion, antibody addition or RNA interference [30] ) or rescued by artificially increasing the concentration of the suspected target in the assay [31, 32] .
Recent advances in transcriptional profiling paved the way for compound specificity studies in a global, cellular context [33] . Marton and colleagues applied this approach to show that 3-aminotriazole (3-AT), an inhibitor of His3p (an enzyme involved in histidine biosynthesis), causes more than 1000 changes in the expression profile of wildtype yeast cells. However, almost no changes in transcript level were observable when yeast cells deleted for HIS3 were treated with 3-AT, indicating that 3-aminotriazole is a specific inhibitor of His3p in yeast cells [34] .
What have we learned from use of small molecules?
The application of small molecules continues to have an enormous impact on our understanding of cell biology. There is an almost endless list of examples where small molecules, in combination with genetic screens, has facilitated the dissection of complex cellular processes. A famous example is the use of the microtubule poison benomyl to arrest yeast cells at the G2-M transition in a forward-genetic screen designed to identify genes involved in cell-cycle control [35, 36] . However, the value of small molecules in answering cell-biological questions is clearly not limited to their ability to synchronize cultured cells [37] . Even in Saccharomyces cerevisiae, one of the most widely used model organisms for genetic manipulations, small molecules have provided insights into fundamental biological processes that have not been accessible by classical genetic approaches. For example, the actindepolymerizing activity oflatrunculin A, a natural product isolated from the sponge Latrunculia magnifica, has been used to unravel the role of the actin cytoskeleton in cell polarity and mitotic spindle orientation in budding yeast [38] (for review, see [39] ). Similarly, the use of splitomicin demonstrated for the first time that continuous histone deacetylase activity of Sir2p is required for maintaining a transcriptionally silenced state in nondividing yeast cells [40] . In these two studies, small molecules were more successful than genetic approaches because the available conditional mutants did not possess the required temporal resolution (in the former case) or because conditional mutants were not available (in the latter case).
New and exciting insights into mitosis and its regulation in mammalian cells were facilitated by the discovery ofthe small molecules monastrol [41] and blebbistatin [42] . Monastrol, initially identified in a whole-cell immunoassay designed to identify compounds that arrest tissue-culture cells in mitosis (see Table 1 ), causes a remarkable phenotype in that the normal bipolar spindle is replaced by an array of microtubules surrounded by a ring of chromosomes (see Fig. 4) . A strikingly similar phenotype had been previously observed when antibodies directed against the mitotic kinesin Eg5 were il\iected into tissue-culture cells [43] . This suggested that Eg5 could be a potential target of monastrol, and indeed motility assays demonstrated that monastrol inhibits Eg5-dependent movement of microtubules in vitro. Owing to its fast mode of action, specificity and reversibility [41, 44] , monastrol opened up new opportunities to elucidate the function of Eg5 in mitosis. Particular, the provocative idea of the existence of a static spindle matrix re-emerged with the observation that, in Xenopus extracts, Eg5 remains static within the spindle when its motor activity is inhibited by monastrol, whereas tubulin, building up the mitotic spindle, constantly moves polewards [45] . Experiments addressing the question of why monastrol-treated cells arrest in mitosis showed that the checkpoint protein MAD2 localizes to a subset of kinetochores in monastrol-treated cells, suggesting the spindle assembly checkpoint is activated in these cells [44] . Moreover, closer examination of monastrol-treated cells revealed MAD2 staining of kinetochores that are clearly attached to microtubules (see Fig. 4 ). This observation challenges the proposal that microtubule attachment rather than tension regulates association of MAD2 with mammalian kinetochores [46] .
Blebbistatin was identified in a pure-protein screen for inhibitors of non-muscle myosin n, which provides the force for the contraction of the cleavage furrow (a ring composed of actin and actin-binding proteins such as myosin II and anillin) during cytokinesis. In vivo, blebbistatin rapidly inhibits the ingression of the cleavage furrow, causing cells to arrest at the end of mitosis with unseparated daughter cells. By adding nocodazole to blebbistatin-treated cells, Straight et al. could demonstrate that microtubule-to-cortex communication is continuously required to maintain the localization of myosin nand anillin at the cleavage furrow. Further experiments using blebbistatin in combination with proteasome inhibitors revealed that exit from cytokinesis in mammalian cells depends on ubiquitin-dependent proteolysis.
Novel insights into the regulation of programmed cell death (apoptosis) were facilitated by the recent discovery of the small molecule PETCM [a-(trichloromethyl)-4-pyridine-ethanoll [47] . Wang and coworkers identified PETCM in a high-throughput screen for activators of caspase-3 in an in vitro cell death assay. Searching for the proteins that mediate the PETCM pro-apoptotic effect, Wang and colleagues identified the oncoprotein prothymosin-a (ProT) and the tumor-suppressor putative HLA-DR-associated proteins (PHAPs) as important regulators of caspase-3 activation, albeit with opposing effects. PHAP proteins appear to be positive regulators of apoptosis, whereas ProT has an anti-apoptotic function by iI'lhibiting the formation of the apoptosome (a macromolecular complex required for the activation of caspase-9, which in turn activates caspase-3). Further experiments demonstrated that PETCM inhibits the anti-apoptotic activity of ProT and thereby promotes the formation of active caspase-3 in the in vitro cell-death assay. The antiapoptotic activity ofProTwas confirmed by the observation that depletion of ProT by RNA interference sensitizes cultured cells to apoptosis.
A whole collection of small molecules, including brefeldin A, nocodazole, ilimaquinone and okadaic acid, has facilitated important insights into the biology of the Golgi apparatus (reviewed in [48] ). These compounds were instrumental, for example, in establishing the cytoskeletal anchoring of the Golgi apparatus close to the MTOC (nocodazole) and in unraveling retrograde flow mechanisms in the secretory pathways (brefeldin A). Similarly, tunicamycin and related inhibitors facilitated the dissection of glycoprotein biosynthesis in a wide range of experimental systems (reviewed in [49] ). In these and many other fields of cell biology, small molecules constitute well-established experimental tools to address important problems that are often difficult to approach by other means. In other fields, however, such as neurobiology, developmental biology or cellular microbiology, the use of small molecules has only just begun [50, 51] . One example showing the value of chemical genetics in neurobiology is provided by the recent study on the function ofmyosin-1c in adaptation in hair cells (the process by which the ear's sensitivity to sound is changed by the presence of a constant sound) [52] . By expressing a mutant form of myosin-1c susceptible to inhibition by N6-modified ADP analogs in utricular hair of transgenic mice, Holt et al. were able to show that the ADP analog largely blocks the ability of these cells to adapt to mechanical stimuli, suggesting that myosin-1c participates in adaptation in hair cells. This inhibition was specific for the engineered mysoin-1c because adaptation in transgenic mice expressing wild-type Myo-1c was entirely normal, even in the presence of the ADP analog.
Concluding remarks
There is no doubt that small molecules have proven themselves as invaluable tools for cell biology. However, it is important to bear in mind that the value of chemical genetics is inseparably tied to the quality of the applied molecules, with compound specificity representing the most crucial issue. In the light of this challenge, a combined effort on the part of chemists and biologists is required to generate novel, highly diverse libraries of small molecules, to design suitable screening approaches and finally to validate the binding partners of active compounds as the relevant targets in vivo. Given the enormous progress that has been made in each of these fields, chemical genetics will have a rapidly growing impact on modern biology.
